Cuorips Inc.
4894.T
Get informed when a big investor buys or sells
+ FollowMarket Cap$52.1B
Close$
Share Statistics
| Market cap | $52.10 Billion |
|---|---|
| Enterprise Value | $48.78 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-124.55 |
| Beta | 0.88 |
| Outstanding Shares | 8,257,861 |
Return
| Return on Equity | -25.66% |
|---|---|
| Return on Assets | -23.69% |
| Return on Invested Capital | -26.66% |
Valuation & Multiples
| P/E Ratio | -45.61 |
|---|---|
| PEG | -78.08 |
| Price to Sales | 420.67 |
| Price to Book Ratio | 11.71 |
| Enterprise Value to Revenue | 379.35 |
| Enterprise Value to EBIT | -40.04 |
| Enterprise Value to Net Income | -43 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 13, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Cuorips Inc.
51 employees
CEO: Takayuki Kusanagi Cuorips Inc. specializes in the comprehensive lifecycle of iPS cell-derived cardiomyocyte sheets, undertaking their research, development, production, commercialization, and distribution. The firm's portfolio extends to include cellular,...